Moolec Science (MLECW) Notes Payables (2023 - 2026)
Moolec Science (MLECW) posted Notes Payables of $50.6 million for Q1 2026, up 23.4% sequentially from $41.0 million in Q4 2025.
Moolec Science (MLECW) Notes Payables (2023 - 2026) Analysis & Trends
Moolec Science has reported Notes Payables for 4 years, with the latest figure at $50.6 million in Q1 2026.
- Quarterly Notes Payables changed N/A year-over-year to $50.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.6 million (changed N/A YoY) and the FY2025 annual result came in at $227.2 million, down 3.14% from the prior year.
- Notes Payables climbed to $50.6 million in Q1 2026 per MLECW's latest filing, from $41.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $234.5 million in Q2 2024 and troughed at $41.0 million in Q4 2025.
- A 4-year average of $146.7 million and a median of $180.0 million in 2023 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2024 and 2025: Notes Payables soared 30.28% in 2024, then declined 3.14% in 2025.
- Over 4 years, Notes Payables stood at $180.0 million in 2023, then surged by 30.28% to $234.5 million in 2024, then plunged by 82.51% to $41.0 million in 2025, then grew by 23.4% to $50.6 million in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $50.6 million, $41.0 million, and $227.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.60 Mn |
| Dec 31, 2025 | 41.01 Mn |
| Jun 30, 2025 | 227.15 Mn |
| Jun 30, 2024 | 234.51 Mn |
| Jun 30, 2023 | 180.00 Mn |